Target intelligence / Profile preview

Retrotransposon Gag-like protein 5 (RTL5)

Target
RTL5
Molecular classification
Other (retrovirus-derived, Gag-like LTR retrotransposon family)[1][3]
01

Overview

Retrotransposon Gag-like protein 5 (RTL5) is a protein encoded by the RTL5 gene in humans and other eutherian mammals. RTL5 is a member of the eutherian-specific, retrovirus-derived Gag-like (RTL) gene family, thought to be functionally exapted from extinct retroviruses. The RTL5 gene, strongly conserved across eutherians, encodes a strongly acidic protein expressed predominantly in microglia in the brain[1]. RTL5, together with its paralog RTL6, is involved in the front-line innate immune response of brain microglia to certain pathogens, such as double-stranded RNA, lipopolysaccharide, and bacterial CpG DNA. RTL5 accumulates in the cytoplasm of microglia and appears to mediate the clearance of these pathogens, likely as a mechanism to prevent infection in the central nervous system[1]. RTL5 is not classified as a conventional drug target such as a receptor, enzyme, or transporter, and there are currently no known drugs or approved therapeutic interventions targeting it, nor is it established as a biomarker or as directly involved in human disease[1][6].

Other names
KIAA2001RGAG4Mar5Mart5SIRH8Retrotransposon gag domain-containing protein 4Sushi-Ichi retrotransposon homolog 8mammalian retrotransposon-derived 56430402L03RikMAR5MART5retrotransposon Gag-like protein 5retrotransposon gag domain containing 4retrotransposon gag domain-containing protein 4[2][5]
02

Biological functions

Innate immune response (specifically in microglia)Pathogen clearance in the brain (including double-stranded RNA and non-methylated DNA)[1]
03

Disease associations

Other (no well-established role as a disease driver or therapeutic target; implicated in brain immune response)[1]

Beyond the preview

Go deeper on Retrotransposon Gag-like protein 5 (RTL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retrotransposon Gag-like protein 5 (RTL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call